India's coronavirus vaccine, COVAXIN, likely effective against new British variant: Study
A study conducted by Indian Council of Medical Research (ICMR) on Covaxin showed a comparable neutralization activity of the vaccinated individuals against UK-variant strain. Covaxin, an indigenously developed and manufactured by Hyderabad based Bharat Biotech in collaboration with ICMR and National Institute of Virology (NIV).
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | Coronavirus | COVID-19 | India Health | Pharmaceuticals | Research | Study | UK Health | Vaccines | Virology